Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: A consecutive cross-sectional survey

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 8, 2010, Pages 775-781

  Wang, Yi Long ^a   Wu, Di ^a   Nguyen Huynh, Mai N ^b   Zhou, Yong ^a   Wang, Chun Xue ^a   Zhao, Xing Quan ^a   Liao, Xiao Ling ^a   Liu, Li Ping ^a   Wang, Yong Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antithrombotic therapy; ischaemia quality of care; stroke; transient ischaemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE; WARFARIN;

AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ISCHEMIA; CHINA; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISABILITY SEVERITY; DISEASE ASSOCIATION; FEMALE; GOVERNMENT INSURANCE; HEALTH INSURANCE; HEART ATRIUM FIBRILLATION; HUMAN; INSURANCE; INTERVIEW; LABOUR INSURANCE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; QUESTIONNAIRE; SALARY; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; ALCOHOL DRINKING; BRAIN ISCHEMIA; CHINA; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DRUG PRESCRIPTIONS; FEMALE; FIBRINOLYTIC AGENTS; HEALTH CARE SURVEYS; HUMANS; INSURANCE, HEALTH; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT COMPLIANCE; PLATELET AGGREGATION INHIBITORS; QUALITY CONTROL; SMOKING; SOCIOECONOMIC FACTORS; STROKE;

EID: 77955120062     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05393.x     Document Type: Article

References (19)

1. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: Epidemiology, prevention, and management strategies. Lancet Neurol. 2007 6:456 464.
2. Wu Z, Yao C, Zhao D et al. Sino-MONICA project: A collaborative study on trends and determinants in cardiovascular diseases in China, Part I: Morbidity and mortality monitoring. Circulation 2001 103:462 468.
3. Wang YL, Wu D, Liao XL, Zhang W, Zhao XQ, Wang YJ. Burden of stroke in China. Int. J. Stroke 2007 2:211 213.
4. Jiang B, Wang WZ, Chen H et al. Incidence and trends of stroke and its subtypes in China: Results from three large cities. Stroke 2006 37:63 8.
5. Liu LS, Gong LS, Wang W. Effects of blood pressure lowering treatment on stroke recurrence in patients with cerebrovascular diseases: A large-scale, randomized, placebo controlled trial. Zhonghua Xin Xue Guan Bing Za Zhi 2005 33:613 617 (in Chinese).
6. Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003 34:2361 2366.
7. Liu L. Cardiovascular diseases in China. Biochem. Cell Biol. 2007 85:157 163.
8. The Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996 348:633 638.
9. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 324:71 86.
10. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischemic stroke and transient ischemic attack. Cerebrovasc. Dis. 2008 25:457 507.
11. Beijing Neurology Club (BNC) Cerebrovascular Diseases Practice Guideline Committee. BNC Practice Guideline of Cerebrovascular Diseases. People's Medical Publishing House, Beijing. 2003 (in Chinese).
12. China Guideline for Cerebrovascular Disease Prevention and Treatment Coordinating Committee. China Guideline for Cerebrovascular Disease Prevention and Treatment, 1st edn. Chinese Medical Association, Beijing. 2005 (in Chinese).
13. Scholte op Reimer WJ, Dippel DW, Franke CL et al. Quality of hospital and outpatient care after stroke or transient ischemic attack: Insights from a stroke survey in the Netherlands. Stroke 2006 37:1844 1849.
14. Mendis S, Abegunde D, Yusuf S et al. WHO study on Prevention of REcurrences of Myocardial Infarction and Stroke (WHO-PREMISE). Bull. World Health Organ. 2005 83:820 829.
15. Wang Y, Wu D, Wang Y, Ma R, Wang C, Zhao W. A survey on adherence to secondary ischemic stroke prevention. Neurol. Res. 2006 28:16 20.
16. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): A major international collaboration. WHO MONICA Project Principal Investigators. J. Clin. Epidemiol. 1988 41:105 114.
17. Wong CK, Lo VI, Tang KL. China's Urban Health Care Reform: From State Protection to Individual Responsibility. Lexington Books
18. Xu L, Wang Y, Collins CD, Tang S. Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003. BMC Health Serv. Res. 2007 7:37.
19. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 1994 154:1449 1457.